About Dr. Jarret Morrow, MD, CCFP, FRACGP

About Dr. Jarret Morrow, MD, CCFP, FRACGP

Dr. Jarret Morrow, MD, CCFP, FRACGP, is a highly experienced General Practitioner and cosmetic physician at the Cottage Medical Centre in Grovedale (Geelong area), with over a decade of expertise in aesthetic medicine. He possesses advanced training in cosmetic injectables, including wrinkle relaxers, dermal fillers, sclerotherapy, and fat dissolvers, and is recognized for developing innovative techniques to meet his clients’ aesthetic aspirations.

His comprehensive background includes working as a rural emergency physician and hospitalist in Canada. Dr. Morrow has garnered acclaim for his contributions to research and medical education, earning him awards and the role of Assistant Clinical Professor at the University of Alberta’s Department of Family Medicine, his alma mater. Moreover, his scholarly pursuits have led to published research in the medical field.

A proponent of continuous professional development, Dr. Morrow has honed his skills with leading physicians in cosmetic medicine across Canada and the United States. As a testament to his broad intellectual interests, he is an active member of both Mensa Canada® and American Mensa®. Dr. Morrow’s comprehensive approach to aesthetic medicine is underpinned by his commitment to personalized patient care and ongoing contribution to medical education.

Dr. Jarret Morrow

Memberships

  • Royal Australian College of General Practitioners (FRACGP)
  • Canadian Medical Association
  • College of Family Physicians of Canada
  • Mensa Canada and American Mensa
  • You can also reference his Google Scholar Page.
  • AHPRA Registered. MED0002607469

Dr Jarret Dean Morrow

Medical Practitioner 

Specialist   No. MED0002607469

A Little Bit About Dr. Jarret Morrow…

Dr. Morrow grew up in Canada with a diverse background and interest in sports. During high school, he competed on his school swim team (Harry Ainlay Composite) as well as on the Alberta Provincial Cycling and Provincial Biathlon (winter) teams. While competing in bicycle racing, he won numerous events including at the Alberta Provincial Cycling Championships (individual pursuit, road race, and time trial). He also placed 3rd in the Canadian National Cycling Championships (road race).

More About Dr. Jarret Morrow…

Dr. Morrow is a husband to his wife Katherine and father to his son Tyler (and now twins Emma and Colin).

Dr. Morrow received his Doctor of Medicine from the University of Alberta in June 2001 and prior to that, received his Bachelor of Science with Specialization in Pharmacology with Distinction, also from the University of Alberta, in June 1997.

He went on to complete his residency training in family medicine also at the University of Alberta, 2013 where he was awarded the University of Alberta Family Medicine Resident Scholarship award.

Selected Publications:

  1. Donna Manca; Kim Duerksen; Brian Forst; Dave Jackson; Karim Keshavjee; Ken Martin; Jarret Morrow; Rick Birtwhistle. The Canadian Primary Care Sentinel Surveillance Network: Knowledge Exchange by Bridging the Evidence-Practice Gap. NAPCRG Meeting. November 15, 2011.
  2. Jean-Michel Le Melledo, Jorge Perez-Parada, Jarret Morrow, Francois Bellavance, Nathalie Lara, Farideh Jahandar, Robert Granger, Glendon Tait, and Karen McManus. Pentagastrin-induced hemoconcentration in healthy volunteers and patients with panic disorder: effect of pretreatment with ethinyl estradiol.  J Psychopharmacol. 2011 Jan;25(1):71-7 [Pubmed]
  3. Psychiatric Clinical Skills, Revised 1ST edition.  Jarret Morrow, Mark Katz, Gary Rodin.  Editor:  David S. Goldbloom. Publisher:  Center for Addiction and Mental Health, Toronto.  2010.  Chapter 16 “Assessment of Medical/Surgical Patients.” [CAMHX.ca]
  4. Jean-Michel Le Melledo, Jorge Perez-Parada, Jarret Morrow, Francois Bellavance, Nathalie Lara, Farideh Jahandar, Robert Granger, Glendon Tait, and Karen McManus.  Pentagastrin-induced hemoconcentration in healthy volunteers and patients with panic disorder: effect of pretreatment with ethinyl estradiol.  Journal of Psychopharmacology;2009: October 13th. [sagepub.com]
  5. Jarret D. Morrow, Mark Katz, Gary Rodin. Assessment of Medical/Surgical Patients. Psychiatric Clinical Skills.  Editor:  David S. Goldbloom.  Publisher:  Elsevier.  Toronto, Ontario. 2006. 215-227. [Google Books]
  6. Morrow J, Castillo M, Gill L, Bradley J, Lara N, Chrapko W, Le Melledo J. Antipanic Effects of Paroxetine on the Panic Response to Pentagastrin in Healthy Controls and Patients with Panic Disorder. Psychosomatic Medicine 2004; 64 Abstract #1585.
  7. Morrow J, Tait G, McManus K, Bellavance F, Lara N, and Le Mellédo J. Pentagastrin-induced Release of Free Fatty Acids in Healthy Volunteers and Patients with Panic Disorder. Effect of Pretreatment with Ethinyl Estradiol.  J Psychiatry Neurosci 2003;28(2):127-33. [Pubmed.com]
  8. Morrow J, Tait G, McManus K, Bellavance F, Lara N, and Le Mellédo J. Pentagastrin-induced Hemoconcentration in Healthy Volunteers and Patients with Panic Disorder. Effect of Pretreatment with Ethinyl Estradiol.  Psychosomatic Medicine 2002;64(1): 117 (Abstract).
  9. Le Melledo J-M, Lara N, Bailey D, Morrow J, Archer S, Juracz P, Radomski M, Chrapko W, Baker G, Bellavance F.  Anxiety Disorders and cerebro-cardiovascular risks. ADAA Toronto, March 2003.7.
  10. Le Melledo J-M, McManus K, Tait G, Morrow J, Bellavance F. Investigation of the Cardiovascular Risks Associated with Panic Disorder.  Biological Psychiatry meeting, Washington 1999.
  11. Le Melledo J-M, McManus K, Tait G, Morrow J, Bellavance F. Investigation of the Cardiovascular Risks Associated with Panic Disorder. CCNP meeting, Halifax, June 1999.
Scroll to Top